Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Learn why monthly financial reviews matter for budgeting success. This intro outlines the routine and benefits of regular financial checks.
24,361 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Talkspace stock surged today as investors responded to stronger-than-expected results and improving unit economics. T...
Amazon has built a multi-engine growth machine spanning cloud, commerce, and ads. This guide explains why it could be...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
Upwork stock has fallen this year as a big investor sold a multi-million stake, raising questions about the company’s...
Nebius Group stock down today has traders watching a broader AI data-center trend. This guide breaks down what moves ...
Nvidia is moving beyond chips into AI agents, changing how businesses deploy AI and how investors should value the co...
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
June volatility has weighed on semiconductor stocks, but a window is emerging for selective buys. Here are three name...
Artificial intelligence is driving a copper demand surge that outpaces supply. This article breaks down why this meta...
The chip market has cooled as investors weigh AI infrastructure costs. This piece highlights three AI chip stocks to ...
A close look at the stock most likely to join the $1 trillion club soon. Learn the catalysts, how to buy, and risk co...